Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals Statistics

Total Valuation

ARMP has a market cap or net worth of $52.83 million. The enterprise value is $170.05 million.

Market Cap	52.83M
Enterprise Value	170.05M

Important Dates

The last earnings date was Thursday, March 20, 2025, after market close.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

ARMP has 36.18 million shares outstanding. The number of shares has increased by 63.71% in one year.

Current Share Class	36.18M
Shares Outstanding	36.18M
Shares Change (YoY)	+63.71%
Shares Change (QoQ)	+63.30%
Owned by Insiders (%)	0.20%
Owned by Institutions (%)	3.84%
Float	11.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.20
Forward PS	n/a
PB Ratio	-1.10
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	32.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.23

Current Ratio	0.23
Quick Ratio	0.21
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.95

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-28.70%
Return on Invested Capital (ROIC)	-31.80%
Return on Capital Employed (ROCE)	-111.12%
Revenue Per Employee	$78,394
Profits Per Employee	-$286,606
Employee Count	66
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.07% in the last 52 weeks. The beta is 0.90, so ARMP's price volatility has been lower than the market average.

Beta (5Y)	0.90
52-Week Price Change	-65.07%
50-Day Moving Average	1.98
200-Day Moving Average	2.30
Relative Strength Index (RSI)	26.34
Average Volume (20 Days)	17,227

Short Selling Information

The latest short interest is 7,691, so 0.02% of the outstanding shares have been sold short.

Short Interest	7,691
Short Previous Month	7,052
Short % of Shares Out	0.02%
Short % of Float	0.07%
Short Ratio (days to cover)	0.69

Income Statement

In the last 12 months, ARMP had revenue of $5.17 million and -$18.92 million in losses. Loss per share was -$0.89.

Revenue	5.17M
Gross Profit	-29.25M
Operating Income	-42.44M
Pretax Income	-79.58M
Net Income	-18.92M
EBITDA	-41.11M
EBIT	-42.44M
Loss Per Share	-$0.89

Balance Sheet

The company has $9.29 million in cash and $126.52 million in debt, giving a net cash position of -$117.22 million or -$3.24 per share.

Cash & Cash Equivalents	9.29M
Total Debt	126.52M
Net Cash	-117.22M
Net Cash Per Share	-$3.24
Equity (Book Value)	-48.02M
Book Value Per Share	-1.33
Working Capital	-36.94M

Cash Flow

In the last 12 months, operating cash flow was -$37.55 million and capital expenditures -$1.88 million, giving a free cash flow of -$39.43 million.

Operating Cash Flow	-37.55M
Capital Expenditures	-1.88M
Free Cash Flow	-39.43M
FCF Per Share	-$1.09

Margins

Gross Margin	n/a
Operating Margin	-820.18%
Pretax Margin	-365.60%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARMP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-63.71%
Shareholder Yield	-63.71%
Earnings Yield	-35.81%
FCF Yield	-74.64%

Analyst Forecast

The average price target for ARMP is $7.00, which is 379.45% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	379.45%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ARMP has an Altman Z-Score of -6.93 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.93
Piotroski F-Score	3